Athens Medical C.S.A. (IATR) — Strategic Asset Allocation Index
Athens Medical C.S.A. (IATR) has a Strategic Asset Allocation Index of 237.6% as of June 2023. Strategic assets (PP&E of €258.41 Million plus long-term investments of €-) total €258.41 Million, measured against net assets of €108.78 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Athens Medical C.S.A. to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Athens Medical C.S.A. Strategic Asset Allocation Index (2014–2022)
This chart shows how Athens Medical C.S.A.'s Strategic Asset Allocation Index has evolved across 9 annual periods from 2014 to 2022. As of June 2023, the index stands at 237.6%, representing strategic assets of €258.41 Million against net assets of €108.78 Million EUR. For live market cap and overall valuation, see IATR market cap overview.
Annual Strategic Asset Allocation Index for Athens Medical C.S.A. (2014–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Athens Medical C.S.A. from 2014 to 2022, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Athens Medical C.S.A. shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 246.6% | €254.66 Million | €254.66 Million | €- | €103.25 Million | ▲ +2.0 pp |
| 2021 | 244.6% | €249.69 Million | €249.69 Million | €- | €102.06 Million | ▼ -41.7 pp |
| 2020 | 286.3% | €249.27 Million | €249.27 Million | €- | €87.07 Million | ▼ -27.3 pp |
| 2019 | 313.6% | €248.00 Million | €248.00 Million | €- | €79.08 Million | ▼ -3.8 pp |
| 2018 | 317.4% | €227.32 Million | €227.32 Million | €- | €71.62 Million | ▼ -37.8 pp |
| 2017 | 355.2% | €224.39 Million | €224.39 Million | €- | €63.18 Million | ▼ -21.3 pp |
| 2016 | 376.5% | €228.36 Million | €228.25 Million | €109.00K | €60.65 Million | ▼ -19.1 pp |
| 2015 | 395.6% | €232.81 Million | €232.71 Million | €101.00K | €58.85 Million | ▲ +68.3 pp |
| 2014 | 327.4% | €241.61 Million | €241.51 Million | €98.00K | €73.81 Million | — |